[1]Langer R, Vacanti JP.T5110 engineering[J].Science,1993,260(5110):920-926.[2] 魏欣苗.抗骨结核药物控释微球支架的多级构建及药物缓释研究[D]. 广州:华南理工大学,2011[3] Williams DF.Biocompatibility of Clinical Implant Materials [M].Boca Raton:CRC Press,1981:209-232.[4]Seal BL, Otero TC, Panitch A.Polymeric biomaterials for t4/5 and organ regeneration[J].Mater Sci Eng R,2001,34(4/5):147-230.[5]陆彬.药物新剂型与新技术[M].北京:人民卫生出版社,1998:27[6]Bezemer JM, Radersma R, Grijpma DW, et al.Microspheres for protein delivery prepared from amphiphilic multiblock copolymers. 2. Modulation of release rate[J].J Control Release,2000,67(2/3):249-260.[7]Borden M, Attawia M, Khan Y, et al.T2 engineered microsphere-based matrices for bone repair: design and evaluation[J].Biomaterials,2002,23(2):551-559.[8] 沈士倩,王家伟.微球细胞支架在骨组织工程中的应用 [J].中国组织工程研究与临床康复,2009,13(34):6749-6752.[9]Jaklenec A, Wan E, Murray ME, et al.Novel scaffolds fabricated from protein-loaded microspheres for t2 engineering[J].Biomaterials,2008,29(2):185-192.[10]Borden M, Attawia M, Laurencin CT.The sintered microsphere matrix for bone t3 engineering: in vitro osteoconductivity studies[J].J Biomed Mater Res,2002,61(3):421-429.[11]Shi X, Wang Y, Ren L, et al.A novel hydrophilic poly(lactide-co-glycolide)/lecithin hybrid microspheres sintered scaffold for bone repair[J].J Biomed Mater Res A,2010,92(3):963-972.[12]Huang W, Shi X, Ren L, et al.PHBV microspheres--PLGA matrix composite scaffold for bone t15 engineering[J].Biomaterials,2010,31(15):4278-4285. |